Arthritis: Types, Symptoms, and Comprehensive Treatment Guide

Understanding Arthritis

Arthritis is not a single disease—it's an informal way of referring to joint pain or joint disease. More than 100 different types of arthritis and related conditions exist, affecting over 350 million people worldwide and 54 million adults in the U.S. While commonly associated with aging, arthritis affects people of all ages, including children.

The term "arthritis" literally means joint inflammation (arthro = joint, itis = inflammation). However, not all types of arthritis involve significant inflammation—the spectrum ranges from purely degenerative (wear-and-tear) to autoimmune-driven inflammatory conditions.

Major Types of Arthritis

Osteoarthritis (OA) - "Wear and Tear"

Prevalence: Most common type, affecting ~32 million U.S. adults

Pathology: Breakdown of joint cartilage, bone remodeling, osteophyte (bone spur) formation. NOT purely wear-and-tear—active inflammatory processes contribute.

Risk Factors:

• Age (primary risk factor)
• Obesity (knee OA: 1 lb weight gain = 4 lb load increase on knees)
• Joint injury (ACL tear, meniscus injury)
• Repetitive stress (occupational, sports)
• Genetics (heritability ~40-60%)
• Female sex (higher prevalence after menopause)

Typical Presentation:

• Gradual onset (months to years)
• Deep, aching joint pain worsened by use, improved with rest
• Morning stiffness ＜30 minutes
• Joint swelling, crepitus (crackling sensation)
• Functional limitation (difficulty climbing stairs, opening jars)

Rheumatoid Arthritis (RA) - Autoimmune

Prevalence: ~1.5 million U.S. adults (0.6% of population)

Pathology: Autoimmune attack on synovium (joint lining), causing inflammation, cartilage damage, bone erosion. Systemic disease affecting multiple organ systems.

Risk Factors:

• Female sex (2-3x more common in women)
• Age 40-60 (can occur at any age)
• Genetics (HLA-DRB1 shared epitope)
• Smoking (doubles risk, worse outcomes)
• Obesity (reduces treatment response)
• Periodontal disease (possible microbial trigger)

Typical Presentation:

• Symmetric joint involvement (hands, wrists, feet)
• Prolonged morning stiffness (＞1 hour)
• Constitutional symptoms: fatigue, low-grade fever, malaise
• Rheumatoid nodules (firm lumps under skin, ~20% of patients)
• Systemic manifestations: lung disease, heart disease, osteoporosis

Gout - Crystal-Induced

Prevalence: ~9 million U.S. adults (3.9% of population)

Pathology: Deposition of monosodium urate crystals in joints, triggering intense inflammatory response. Results from hyperuricemia (elevated uric acid).

Risk Factors:

• Male sex (until menopause, then risk equalizes)
• Obesity, metabolic syndrome
• Diet high in purines (red meat, seafood, alcohol—especially beer)
• Genetics (SLC2A9, ABCG2 variants)
• Kidney dysfunction (reduced uric acid excretion)
• Diuretics (thiazides, loop diuretics)

Typical Presentation:

• Sudden, severe joint pain (often at night)
• First MTP joint (big toe) affected in 50% (podagra)
• Intense inflammation: red, hot, swollen, extremely tender
• Attacks last 3-10 days without treatment, then resolve completely
• Recurrent attacks lead to chronic gouty arthritis, tophi (urate deposits)

Diagnosis

Clinical Evaluation

Joint Examination:

• Inspection: Swelling, redness, deformity, alignment
• Palpation: Warmth, tenderness, effusion
• Range of motion: Active and passive, crepitus
• Stability: Ligament testing
• Functional assessment: Gait, grip strength, timed activities

Laboratory Tests:

| Test | Osteoarthritis | Rheumatoid Arthritis | Gout | |------|----------------|----------------------|------| | ESR/CRP | Normal/mildly elevated | Elevated | Elevated during attack | | Rheumatoid factor (RF) | Negative | Positive in 70-80% | Negative | | Anti-CCP | Negative | Positive in 70% (more specific) | Negative | | Uric acid | Normal | Normal | Elevated (but can be normal during attack) | | Synovial fluid | Non-inflammatory | Inflammatory | Crystals visible |

Imaging:

• X-ray: First-line for OA (joint space narrowing, osteophytes, subchondral sclerosis)
• Ultrasound: Detects synovitis, erosions, crystals (useful for RA, gout)
• MRI: Early OA (bone marrow lesions), RA (synovitis, erosions before X-ray)
• CT: Preoperative planning, complex joint anatomy

Diagnostic Criteria:

• ACR/EULAR Criteria for RA: Requires ≥6 points from joint involvement, serology, acute-phase reactants, duration
• ACR Criteria for Gout: Presence of urate crystals in synovial fluid is definitive

Treatment Strategies

Osteoarthritis Management

Nonpharmacologic:

• Weight loss: 10% weight loss → 50% reduction in knee OA pain
• Exercise: Physical therapy, low-impact activities (walking, swimming, cycling)
• Bracing/orthotics: Unloader braces for knee OA, shoe inserts
• Hot/cold therapy: Heat for stiffness, ice for inflammation

Pharmacologic:

• Topical NSAIDs (diclofenac): First-line for hand/knee OA (minimal systemic absorption)
• Oral NSAIDs: Effective but GI, renal, cardiovascular risks
• Acetaminophen: Modest benefit, safer than NSAIDs
• Intra-articular injections: Corticosteroids (short-term relief), hyaluronic acid (viscosupplementation, mixed evidence)
• Duloxetine: SNRI effective for chronic OA pain

Surgical:

• Arthroscopy: Generally NOT recommended (no better than sham surgery for most)
• Osteotomy: Joint-preserving surgery for young patients with malalignment
• Joint replacement: Gold standard for end-stage OA (knee, hip, shoulder)
  • Success rate: 90-95% patient satisfaction at 10 years
  • Recovery: 3-6 months for full function
  • Lifespan: 15-20 years (knee), 20-25 years (hip)

Rheumatoid Arthritis Management

Treat-to-Target Approach:

• Goal: Remission or low disease activity
• Tight control: Frequent monitoring, medication adjustment until goal achieved

DMARDs (Disease-Modifying Antirheumatic Drugs):

| Class | Examples | Onset | Monitoring | |-------|----------|-------|------------| | Conventional synthetic | Methotrexate (first-line), Hydroxychloroquine, Sulfasalazine, Leflunomide | 6-8 weeks | CBC, LFTs, renal | | Biologic | TNF inhibitors (adalimumab, etanercept), IL-6 inhibitors (tocilizumab), B-cell depletion (rituximab) | 2-4 weeks | TB screening, infection risk | | Targeted synthetic | JAK inhibitors (tofacitinib, upadacitinib) | 2 weeks | CBC, lipids, infection risk |

Glucocorticoids:

• Bridge therapy while waiting for DMARDs to work
• Lowest effective dose for shortest duration
• Long-term side effects: osteoporosis, diabetes, cataracts, infection

Nonpharmacologic:

• Physical therapy: Joint protection techniques, strengthening
• Occupational therapy: Assistive devices, joint protection strategies
• Smoking cessation: Improves treatment response, reduces cardiovascular risk

Gout Management

Acute Attack Treatment (start within 24 hours for best effect):

• NSAIDs: Indomethacin, naproxen (first-line for most)
• Colchicine: Effective if given early (dosing: 1.2 mg initially, then 0.6 mg 1 hour later, then 0.6 mg q8-12h)
• Glucocorticoids: Prednisone 30-40 mg daily × 5-10 days, or intra-articular injection

Urate-Lowering Therapy (ULT):

• Indication: Frequent attacks (≥2/year), tophi, urate nephropathy, kidney stones
• First-line: Allopurinol (starting at 100 mg daily, titrate to goal uric acid ＜6 mg/dL)
• Alternative: Febuxostat (for allopurinol-intolerant or CKD)
• Probenecid: Increases uric acid excretion (for underexcreters, normal renal function)

Lifestyle:

• Limit purine-rich foods (red meat, organ meats, shellfish)
• Avoid alcohol (especially beer, spirits)
• Limit fructose-sweetened beverages
• Weight loss if overweight
• Stay hydrated

Lifestyle Modifications for All Types

Exercise

• Low-impact activities: Walking, swimming, cycling, tai chi
• Range of motion: Preserve joint mobility
• Strengthening: Support and stabilize joints
• Avoid: High-impact activities (running, jumping) on affected joints

Weight Management

• Target BMI 18.5-24.9
• Even 5-10% weight loss significantly reduces joint load and pain
• Diet: Mediterranean diet (anti-inflammatory, heart-healthy)

Joint Protection

• Use larger joints when possible (carry load on forearms, not hands)
• Distribute load (use two hands, backpack vs shoulder bag)
• Avoid prolonged static positions
• Use assistive devices (jar openers, grab bars, shoehorns)

Related Conditions

• Lupus: Another autoimmune arthritis
• Psoriatic Arthritis: Inflammatory arthritis with psoriasis
• Fibromyalgia: Chronic widespread pain, not true arthritis

FAQ

References